RNA-binding protein fused in sarcoma/translocated in liposarcoma, also known as heterogeneous nuclear ribonucleoprotein P2 is a protein that in humans is encoded by the FUS gene. From Wikipedia
Ulefnersen, targeting FUS gene mutations, demonstrates safety, biomarker reduction, and functional recovery in early clinical use, with a global trial underway.